Schizophrenia Research
Volume 98, Issue 1 , Pages 1-7 , January 2008

A randomized controlled trial of cognitive-behavior therapy for persistent symptoms in schizophrenia: A five-year follow-up

  • Douglas Turkington

      Affiliations

    • School of Neurology, Neurobiology and Psychiatry, Royal Victoria Infirmary, Leazes Wing, Richardson Road, University of Newcastle, Newcastle upon Tyne, Tyne and Wear, NE1 4LP, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1912824842; fax: +44 1912824839.
    • ,
  • Tom Sensky

      Affiliations

    • Division of Neuroscience and Mental Health, Imperial College, London, UK
    • ,
  • Jan Scott

      Affiliations

    • Department of Psychological Medicine, PO Box 96, Institute of Psychiatry, London, UK
    • ,
  • Thomas RE Barnes

      Affiliations

    • Division of Neuroscience and Mental Health, Imperial College, London, UK
    • ,
  • Ula Nur

      Affiliations

    • Division of Neuroscience and Mental Health, Imperial College, London, UK
    • ,
  • Ronald Siddle

      Affiliations

    • Department of Psychiatry, University of Manchester, Withington Hospital, Manchester, UK
    • ,
  • Katherine Hammond

      Affiliations

    • School of Neurology, Neurobiology and Psychiatry, Royal Victoria Infirmary, Leazes Wing, Richardson Road, University of Newcastle, Newcastle upon Tyne, Tyne and Wear, NE1 4LP, UK
    • ,
  • Neshika Samarasekara

      Affiliations

    • School of Neurology, Neurobiology and Psychiatry, Royal Victoria Infirmary, Leazes Wing, Richardson Road, University of Newcastle, Newcastle upon Tyne, Tyne and Wear, NE1 4LP, UK
    • ,
  • David Kingdon

      Affiliations

    • Mental Health Group, University of Southampton, Southampton, UK

Received 3 July 2007 ,Revised 11 September 2007 ,Accepted 18 September 2007.

References 

  1. American Psychiatric Association . In: Diagnostic and Statistical Manual of Mental Disorders DSM IV. (4th Ed.). Washington: APA; 1993;
  2. Andreasen NC. Scale for the Assessment of Negative Symptoms. Iowa City: University of Iowa; 1981;
  3. Asberg M, Montgomery SA, Perris C, Shalling D, Sedvall G. A comprehensive psychopathological rating scale. Acta. Psychiatr. Scand. 1978;271:5–27
  4. Cannon M, Jones P. Schizophrenia. J. Neur. Neurosur. Psych. 1996;61:604–613
  5. Drury V, Birchwood M, Cochrane R. Cognitive therapy and recovery from acute psychosis: a controlled trial. 3. Five-year follow-up. Br. J. Psychiatry. 2000;177:8–14
  6. Gaebel W, Frommann N. Long-term course in schizophrenia: concepts, methods and research strategies. Acta Psychiatr. Scand. 2000;102(suppl. 407):49–53
  7. Geddes J, Freemantle N, Harrison P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br. Med. J. 2000;321(7273):1371–1376
  8. Gould RA, Mueser KT, Bolton E, Mays V, Goff D. Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophr. Res. 2001;48:335–342
  9. Gumley A, O'Grady M, McNay L, Reilly J, Power K, Norrie J. Early intervention for relapse in schizophrenia: results of a 12 month randomized controlled trial of cognitive-behavioural therapy. Psychol. Med. 2003;33(3):419–431
  10. Haddock G, Devane S, Bradshaw T, McGovern J, Tarrier N, Kinderman P, et al. An investigation into the psychometric properties of the cognitive therapy scale for psychosis (CTS-Psy). Behav. Cogn. Psychother. 2001;29:221–234
  11. Harrison G, Hopper K, Craig T. Recovery from psychotic illness: a 15 and 25 year international follow-up study. Br. J. Psychiatry. 2001;178:506–517
  12. Hogarty GE, Kornblith SJ, Greenwald D. Three year trials of personal therapy among schizophrenic patients living with or independent of family, I: description of study and effects on relapse rates. Am. J. Psychiatry. 1997;154(11):1504–1513
  13. Kane J, Honigfield G, Singer L, Meltzer H. Clozapine for the treatment of the resistant schizophrenic: a double blind trial with chlorpromazine. Arch. Gen. Psych. 1988;45:789–796
  14. Kingdon DG, Turkington D. Befriending schemes: cost-effective community care. Psych. Bull. 1989;13:350–351
  15. Kingdon D, Turkington D. The Case Study Guide to Cognitive Behaviour Therapy of Psychosis. London: Wiley; 2003;
  16. Kingdon D, Turkington D. Cognitive Therapy of Schizophrenia. Guides to Individualized Evidence-Based Treatment. New York: Guilford Press; 2005;
  17. Kirkpatrick B, Fenton WS, Carpenter WT, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schiz. Bull. 2006;32(2):214–219
  18. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N. Engl. J. Med. 1988;318:1728–1733
  19. Leucht S, Barnes TRE, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new generation antipsychotics: a systematic review and explorative meta-analysis of randomized controlled trials.. Am. J. Psychiatry. 2003;160:1209–1222
  20. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005;353:1209–1223
  21. Milne DL. Social Therapy: A Guide to Social Support for Mental Health Practitioners. Chichester: John Wiley; 1999;
  22. Montgomery MA, Asberg MA. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 1979;134:382–389
  23. Montgomery SA, Taylor P, Montgomery D. Development of a schizophrenia scale sensitive to change. Neuropharmacology. 1978;17:1053–1071
  24. National Institute for Clinical Excellence . In: Clinical Guideline1: Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: NICE; 2002;
  25. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, et al. Prevention of relapse in residual depression by cognitive therapy. Arch. Gen. Psych. 1999;56:825–835
  26. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Martindale B, et al. Psychological treatments in schizophrenia: II. Meta-analysis of social skills training and cognitive remediation. Psychol. Med. 2002;32:783–791
  27. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987;
  28. Sensky T, Turkington D, Kingdon D, Scott J, Siddle R, O'Carroll M, et al. A randomised controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Arch. Gen. Psych. 2000;57:165–172
  29. Tarrier N, Barrowclough C, Porceddu K, Fitzpatrick E. The Salford Family Intervention Project: relapse rates of schizophrenia at five and eight years. Br. J. Psychiatry. 1994;165:829–832
  30. Turkington D, Kingdon D, Rathod S, Turkington D. Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia. Br. J. Psychiatry. 2006;189:36–40
  31. Williams L, Newton G, Roberts K, Finlayson S, Brabbins C. Clozapine-resistant schizophrenia: a positive approach. Br. J. Psychiatry. 2002;181(3):184–187
  32. Zimmermann G, Favrod J, Trieu VH, Pomini V. The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis. Schiz. Res. 2005;77:1–9

PII: S0920-9964(07)00431-8

doi: 10.1016/j.schres.2007.09.026

Schizophrenia Research
Volume 98, Issue 1 , Pages 1-7 , January 2008

Article Tools